Neurology Advisor: Infective endocarditis-related stroke more associated with IV drug use
Between 20% and 40% of patients with infective endocarditis, or inflammation of the inner lining and valves of the heart, will have an ischemic stroke event.
Researchers at the University of Cincinnati recently published findings in Neurology that found rates of infective endocarditis-related stroke (IERS) in the U.S. increased from 2005-2015, with affected patients more likely to be intravenous (IV) drug users.
Over time, more patients with IERS were IV drug users and fewer had hypertension. Patients who were drug users were also younger and fewer were women.
Rates of IERS increased from 1.31 per 100,000 in 2005 to 1.66 per 100,000 in 2010 and 2.41 per 100,000 in 2015. Rates of non-endocarditis stroke decreased slightly from 280 per 100,000 in 2005 to 274 per 100,000 in 2015.
“The impact of the opioid epidemic is reflected in the transforming phenotype of IERS," the researchers wrote.
Read the Neurology Advisor article.
Featured photo at top of brain courtesy of iStock.
Related Stories
Pianist, educator and scholar Lynn Worcester Jones joins CCM’s faculty
May 16, 2024
UC College-Conservatory of Music Interim Dean Jonathan Kregor has announced the addition of Lynn Worcester Jones, DMA, to the college’s roster of distinguished performing and media arts faculty members. Jones is an innovative pianist, educator, writer, speaker, mentor and leader who encourages career preparation and excellence in students. She begins her new role as Associate Professor of Piano Pedagogy and Coordinator of Group Piano at CCM on Aug. 15, 2024.
Residents concerned about high concentration of low-income housing
May 16, 2024
Efforts to build more affordable housing in Cincinnati have created concerns for residents as low-income housing has been concentrated in some of the city’s poorest neighborhoods, WCPO reported. Gary Painter, PhD, the academic director of the University of Cincinnati’s Carl H. Lindner College of Business real estate program and a professor of real estate, said a complaint against the city could lead to positive outcomes.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.